Ionizing radiation dose exposure to the ocular region of pain physicians during C-arm guided pain interventions by Kelly, Raymond et al.
UCC Library and UCC researchers have made this item openly available.
Please let us know how this has helped you. Thanks!
Title Ionizing radiation dose exposure to the ocular region of pain physicians
during C-arm guided pain interventions
Author(s) Kelly, Raymond; McMahon, Aisling; Hegarty, Dominic
Publication date 2018-09
Original citation Kelly, R., McMahon, A. and Hegarty, D. (2018) 'Ionizing Radiation
Dose Exposure to the Ocular Region of Pain Physicians During C-arm
Guided Pain Interventions', Pain Physican, 21, pp. E523-E532.






Access to the full text of the published version may require a
subscription.
Rights © 2018 ASIPP Publishing, American Society of Interventional Pain






Background: The growth of interventional pain medicine in recent years has resulted in more 
procedures being carried out under fluoroscopic guidance. The proximity of the pain physician 
(PP) to ionization radiation (IR) potentially increases the risk of radiation exposure to the ocular 
region. A European directive has reduced the limits of occupational ocular dose 7.5-fold.
Objectives: The objectives of this study are to quantify the typical IR exposure in the ocular 
region of PP and to compare it to recommended international guidelines.
Study Design: Three consultants involved in the pain unit service were enrolled in the study 
to reflect the dose implications involved with different caseloads, training obligations, and 
procedure types. All 3 consultants were experienced primary operators.
Setting: The study was undertaken at the pain management suite in the South Infirmary 
Victoria University Hospital (SIVUH). Annually, this unit performs 2,800 fluoroscopic guide pain 
procedures.
Methods: Thermoluminescent dosimeters (TLDs) calibrated to measure eye lens doses [Hp 
(0.07)] and whole-body doses (WBDs) were fitted to 3 pain consultants while they undertook 
imaging-guided pain procedures using mobile C-arm fluoroscopy over a 3-month period. The 
duration of radiation exposure, screening time (seconds), and procedure type were recorded. 
Radiation dose was calculated to estimate the effective radiation dose to the ocular region 
using (i) dose-area product (DAP) in milliGray per centimeter squared (mGycm2) and (ii) Air 
Kerma (AK) values in mGy.
Results: IR doses were effectively recorded in 682 cases over 3 months and the data 
extrapolated. The estimated annual lens dose experienced by pain physicians performing 
fluoroscopy-guided procedures is less than the recommended international guidelines. A 
significant linear relationship between screening time and IR exposure was estimated (rs = 
0.93, P < 0.01)
Limitations: In many centers, including our own, fluoroscopy procedures are undertaken by 
nonconsultant staff. Therefore, a small single-center cohort recruiting experienced consultant 
staff and not including pain fellows or registrars/residents with varying levels of experience is 
a limitation.
Conclusion: While IR to the ocular region was significantly less than the recommended 
European safety guidelines, the annual dose needs to be confirmed in pain physicians with a 
lesser degree of clinical experience.
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and to compare it to recommended international 
guidelines.
Methods
The study was undertaken at the pain manage-
ment suite in the South Infirmary Victoria University 
Hospital (SIVUH). Ethical approval was obtained from 
the Cork Research Ethics Committee (CREC). Annually, 
this unit performs 2,800 fluoroscopy-guided pain pro-
cedures. The room is a lead-lined procedural room with 
dimensions of approximately 32 m2. This is in contrast 
to the National Health Service (NHS) recommendation 
of 39-45 m2 for fluoroscopic or nonvascular interven-
tional fluoroscopy imaging examination rooms that are 
remote from the radiology department (8). The room 
was similar to most other pain procedure settings in all 
other aspects including features such as a radiolucent 
procedure table, lead-lined doors, and appropriate 
warning lights similar to those used in a theater.
A GE OEC Fluorostar 7900 Digital Mobile C-arm (GE 
Healthcare, Dublin, Ireland) is used to provide the imag-
ing guidance in this suite. Quality assurance (QA) based 
on recommended standards and guidelines for radiol-
ogy equipment was confirmed (9). An under-couch 
position in relation to the C-arm was adopted for all 
fluoroscopic procedures. The dose area product (DAP) 
tolerance levels, measure in milliGray per centimeter 
squared (mGycm2), were within normal limits, display-
ing results were within 13% of actual measured DAP 
at the radiation source which is within normal limits as 
per QA standards.
Patients
The 3 consultants involved in the pain unit service 
were enrolled in the study to reflect the dose implica-
tions involved with different caseloads, training obli-
gations, and procedure types. A record of the typical 
procedures was compiled (Table 1). All 3 consultants 
were experienced primary operators (i.e., more than 
5 years post-higher specialist training qualification). 
They all wore wrap-around lead aprons with 0.25 mm 
lead equivalence in each front panel when overlapped, 
providing 0.5 mm lead equivalence total at the wearer’s 
front, and a thyroid collar with 0.5 mm lead equiva-
lence. One of the pain physicians routinely wears lead 
protection glasses. All patients wore personal monitor-
ing thermoluminescent dosimeters (TLD) dose badges 
in accordance with department and legal requirements 
(10).
The growth of interventional pain medicine in recent years has resulted in more procedures being carried out under fluoroscopic guidance. 
In Ireland between 2005 and 2011, for example, pain 
medicine procedures increased by 80% from just under 
4,700 to 8,430 (1). The increase in procedure frequency, 
complexity, and patient numbers has meant that 
pain physicians are now exposed to greater levels of 
ionizing radiation than in the past. While technological 
improvements have made the use of fluoroscopy 
safer, guidelines on radiation protection for the pain 
physician have not kept pace with these advances in 
technology. 
The human eye is more radiosensitive than previ-
ously thought. The proximity of the pain physician to 
ionization radiation (IR) potentially increases the risk of 
radiation exposure to the ocular region and there is a 
recognized risk for the development of a cataract (2-4). 
The International Commission on Radiological 
Protection (ICRP) and the European Union-led Op-
timisation of Radiation Protection for Medical Staff 
(ORAMED) project have recommended equivalent dose 
limits calculated from large longitudinal studies (5). A 
European directive has reduced the limits of the occu-
pational ocular dose 7.5-fold. Anecdotal evidence sug-
gests that ocular or head protection such as shielding 
screens or lead glasses that other interventionists (e.g., 
interventional cardiologists) employ are not routinely 
used by pain clinicians (6,7).
The objective of this study is to quantify the typi-
cal IR exposure in the ocular region of pain physicians 
Table 1. Nonexhaustive list of  typical procedures performed.
Procedure Description














Ionizing Radiation to the Ocular Region During Pain Interventions
Patient Compliance 
Because consultant compliance would have a huge 
bearing on the accuracy of results, compliance and ad-
herence were addressed in 3 ways:
(a) The pain consultants were sent an SMS text mes-
sage 30 minutes prior to their list starting, remind-
ing them to wear their dose badge, and again im-
mediately after the procedure session, requesting 
the number of patients on their list for whom they 
were primary operator 
(b) The nursing manager was asked to ensure that the 
pain consultants wore the TLD badge, which was to 
be attached to the thyroid shield outside the lead 
coat and not caught up beneath the jacket, which 
would render dose results falsely low 
(c) One author (RK) attended the pain management 
unit at the start of several lists to ensure that all 
dosimeters were worn and stored correctly, and to 
obtain patient feedback. 
Ocular Radiation Dose Measures
Ocular radiation dose, calculated as effective dose 
in milliSieverts [mSv], was measured. Two different types 
of TLD dosimeters were used to record ocular radiation 
dose (Fig. 1). The most accurate eye lens dosimeter (ELD) 
has been specially calibrated to Hp(3). The dosimeters 
available for this study were the same as those used for 
eye dose measurement; however, they were calibrated 
to calculate skin dose, Hp(0.07) (LANDAUER, Glenwood, 
IL). Literature provided by LANDAUER indicate that 
these dosimeters are suitable for the purpose we re-
quired, with the caveat of slightly overestimating dose 
values by small amounts (11-14). 
Multiple studies have also shown that the whole-
body dosimeter (WBD) can be used to calculate ocular 
dose satisfactorily when compared to an ELD, provided 
similar radiation protection measures are used (15). 
These studies outline how an unprotected WBD on the 
thyroid collar can be used to estimate eye lens dose 
in eyes unprotected by lead glasses (11,16,17). An ac-
cepted conversion factor to use is: eye dose = 0.75 x 
neck dose (18,19).
Following the measurement periods, the dosim-
eters were returned to medical physics and sent for 
analysis. 
Dose Metrics Recorded
Three dose metrics were recorded for every proce-
dure undertaken by the pain clinician throughout the 
3-month study period:
• Fluoroscopy time recorded in seconds
• Dose-area product (DAP) in milliGray per centime-
ter squared (mGycm2)
• Air kerma (AK) value in mGy  
Fig. 1. A) Eye lens dosimeter used in study 
(coin comparison to illustrate size). B) 
Whole body dosimeter.
A B
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While fluoroscopy time is easy to measure, it is not 
strongly correlated with radiation risk because fluoros-
copy dose rates fluctuate over a wide range of values 
throughout the duration of a procedure, and adjust 
automatically to provide optimal image quality when 
imaging different body areas and densities. Reference 
AK and DAP can more accurately estimate the risk of 
radiation injury, though they are usually used to record 
patient dose.  
DAP is defined as the integral of AK across the x-ray 
beam. The same DAP value can occur with a large field 
and low skin dose as with a small field and high skin 
dose. DAP provides no information regarding the spa-
tial distribution of the entrance beam on the patient’s 
skin. It is a proxy measure of the amount of energy 
delivered to the patient as it is the absorbed radiation 
dose multiplied by the area irradiated (20-22). AK de-
fines the radiation dose accumulated at a specific point 
in space. Although recording these values may not add 
any value to our dosimeter results, we felt it prudent 
to record all available dose data for use in correlating 
dose readings.
These values were recorded by the radiographer 
and scanned into the Picture Archiving and Communi-
cation System (PACS). They are also archived automati-
cally on the C-Arm as part of the metadata with the 
stored images from the procedure. This data is deleted 
manually in chronological order when the local disk 
space nears capacity. Two archives of data ensured that 
all procedures were accurately recorded and could be 
cross-checked in the event of any doubt.
Procedures
Pilot Study
A 4-week pilot study was undertaken to ensure the 
feasibility of accurate data collection. During this time, 
2 eye dosimeters fixed to lead protection glasses were 
worn by one consultant for all interventional proce-
dures using ionizing radiation. While evidence shows 
that the left eye gets irradiated to a greater degree in 
C-Arm-guided interventional procedures, the primary 
operator’s movement during pain procedures – allied to 
the movement of the C-Arm position (Anteroposterior 
[AP] to Oblique to Lateral position) – meant that there 
may be similar exposure to the right eye. Therefore, 
dosimeters for both eyes were analyzed by medical 
physics.
The pain physician participating in the pilot study 
routinely wore lead glasses while performing pain man-
agement procedures, and the left and right dosimeters 
were mounted on the arms of the glasses as close to 
the eyes as possible without impeding vision (Fig. 2). 
The dosimeters were in place for 35 procedures over 
a 4-week period. The pilot study was completed when 
the dose data was obtained and analyzed. Once con-
firmed that it was technically viable to proceed with the 
study, other consultants could be enrolled.
All dosimeters were stored in a locked unit or at 
the nurses’ station in the pain department to prevent 
accidental exposure. Control dosimeters were returned 
along with exposed dosimeters at the end of the pilot 
study.
Main Study
Three pain consultants  were enrolled for the 
3-month period. All pain physicians  were monitored by 
the whole-body chest dosimeter worn on the thyroid 
shield, to address concerns that using dosimeters fixed 
close to the ocular region via a headband would not be 
tolerated. One of the consultants continued to use the 
eye dosimeters in addition to the whole-body dosim-
eter secured to the thyroid shield, as illustrated in Fig. 3. 
Statistical Analysis
Statistical analysis was performed using SPSS 
software (23). Non-parametric tests were used due to 
the abnormal distribution of the data. The correlation 
coefficient between the DAP and screening time was 
used to measure the strength of the linear association 
between the 2 values and support the Hp(0.07) and Hp 
(10) values obtained. Homogeneity of variances across 
Fig. 2. Position of  dosimeters on lead glasses.
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recorded values of screening time and DAP was tested 
prior to discussing the pilot study findings with data 
from the main study.
Results
The pilot study confirmed that positioning of the 
TLD would capture the IR exposure to the ocular region 
(Table 2).
Over the 3-month period, a total of 682 fluoroscopy 
procedures were included in the study. The number and 
type of procedures undertaken are reported in Table 3. 
Of the 682 procedures monitored, consultant 1 per-
formed 26.2% (n = 179) of the procedures, consultant 2 
performed 54.8% (n = 374), and consultant 3 performed 
18.9% (n = 129) of the procedures. It is important to 
note that, although consultant 2 was present for more 
procedures, he may not have been the primary operator 
for the full duration of the procedures. This would have 
been reflected on his whole-body dosimeter reading, 
but not in his screening time or DAP readings. Table 4 
illustrates the average values for all 3 pain physicians . 
The eye dose values recorded over the 3-month 
period were extrapolated to represent annual eye lens 
dose. Percentage figures are in relation to the accepted 
new dose limit of 20mSv. The key finding is that the 
estimated annual lens dose experienced by pain physi-
cians performing fluoroscopy-guided procedures is less 
than the new recommended international guideline of 
20mSv per year (4,24-27).
Variation in the exposure patterns was assessed 
using a stem and leaf plot (represented by the box 
and whisker plots) (Fig. 4). Analysis of these exposure 
patterns revealed that consultant 1 had 7 procedures 
deemed extreme by SPSS in terms of screening time, 
when compared to the other recorded 171 values. With 
respect to DAP, 11 procedures were deemed extreme 
in value compared to the mean (23). Consultant 2 had 
20 procedures deemed extreme in relation to screen-
ing time and 22 in relation to DAP. Consultant 3 had 
12 procedures deemed extreme in both screening time 
and DAP values. 
These outlier values were retained as part of the 
analysis in an effort to present a realistic record of a 
typical procedure profile in our unit. They also high-
light the abnormal distribution of data across patients.
There was a significant positive relationship be-
tween the recorded DAP and the duration of screening 
time for all 3 consultants (Table 5), where a Spearman’s 
correlation coefficient of 1 denotes a perfect correla-
tion and values close to 1 indicate a strong correlation 










14 min 48 
sec 76.51 0.9
Table 3. Basic breakdown of  frequency of  procedure type by 
description, where n = number of  procedures.
Region Examined n (%)
Cervical region 31 (4.5%)
Thoracic region 19 (3%)
Lumbar region 265 (38%)
Sacroiliac/Coccygeal region 64 (9%)
Epidural Injection region unspecified 115 (17%)
Facet joint region unspecified 98 (14%)
Others: 36 (5%)
   Superior hypogastric plexus block
   Ganglion impars sacrococcyl injection
   Pudendal nerve block
   Ischial tuberosity injection
   Piriformis injection
   Intra-articular injection-Ankle/hip
   Plantar fascia injection
Fig. 3. Position of  dosimeter on thyroid shield.
Table 5. Shows the correlation between DAP and duration of  
screening time for each consultant (rs = Spearman correlation; 
Rs
2 = correlation coefficient squared).
Spearmans (rs) rs
2 P (one-tailed)
Consultant 1 0.9 0.81 < 0.01
Consultant 2 0.94 0.88 < 0.01
Consultant 3 0.94 0.89 < 0.01
Average 0.93 0.86 < 0.01
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Table 4. Average values for the group using the whole-body dosimeters and extrapolated annual values.
Screening time (min) 
+1 s.d
Total DAP (mGycm2) 
+1 s.d
Whole body dosimeter 
(mSv) +1 s.d
Conversion factor 
applied (0.75) +1 s.d
Mean of Main Study 
(n = 3) 68.4 + 52.6 307.04 + 260.8 0.91 + 0.5 0.68 + 0.38
Extrapolated Annual Dose (mSv)
Screening time (min) Total DAP (mGycm2)
Whole body Dosimeter 
(mSv)
% of  annual dose
Mean of Main Study 
(n = 3) 273.6 + 210.42 1228 + 1043 2.73 + 1.51 13.7 + 7.55
Fig. 4. Shows box and whisker plots outlining the  distribution of  the recorded. 
A) Screening times and B) DAP (where DAP = . The o and * represent outliers where * is an “extreme” outlier as determined by the SPSS formula: 
1.5 x interquartile range).
A B
between the 2 outlined variables, despite nonlinearity. 
Squaring the data allows one to represent the propor-
tion of shared variance in the 2 ranked variables, DAP 
and screening time. Figure 5 depicts this relationship and 
indicates a positive linear association between DAP and 
screening time despite the data being nonparametric.  
discussion
Our study has shown that pain physicians are ex-
posed to measurable IR to the ocular region; however, 
no pain physician received more than 24% of the new 
ocular dose limit being brought into effect in 2018. 
Our results confirm that a significant linear relation-
ship exists between the screening time duration of the 
procedures and DAP. 
We believe that this is the first study to quantify 
the eye lens IR dose received by pain physicians using 
real time data. It highlights the importance of good in-
terventional practice/skills in maintaining safe IR levels 
and complying with current legislation (28).
With respect to effective radiation dose received in 
the workplace, the health and safety of staff is legally 
protected. The new directive on ocular dose means that 
even more stringent controls in relation to operator 
eye dose are required. Pain medicine continues to be 
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Fig. 5. Scatterplot depicting  rank correlation between DAP and screening time readings recorded for the 3 physicians. The positive 
R2 values indicate a positive association between the 2 variables. Spearman’s correlation coefficient provides a more accurate 
assessment of  monotonic yet nonparametric data, however linear association between the variables is seen.
dependent on ionizing radiation in image-guided pro-
cedures (1). Keeping radiation doses as low as reason-
ably achievable is one of the main tenets of radiation 
protection, and adhering to this principle will help to 
ensure that the pain medicine departments complie 
with current legislation (24). We believe that this study 
provides valuable information on eye dose estimates 
that a typical pain physician may be exposed to during 
a typical work week. This information has potentially 
significant technical and economic implications for all 
concerned.
Our study confirmed that the level of IR used in 
pain procedures can vary substantially between differ-
ent types of procedures, and among individual pain 
physicians who specialize in different procedures. 
Based on this anticipated variation, an approach 
based on “dose per procedure” would have had little 
clinical value. Other factors influencing operator ra-
diation dose include the distance of the operator from 
the patient, the orientation of the operator’s head, 
the distance of the image detector from the patient, 
the beam collimation, the tube configuration, the 
Pain Physician: September/October 2018: 21:E523-E532
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tube voltage and filtration, and the complexity of the 
procedure.  
Post hoc analysis showed low annual extrapolated 
values in the main study. We used average dose and 
screening time results from the main study, bearing in 
mind that we had dose information from two sources: 
the C-arm and the dosimeters. 
One physician (consultant 1) received almost 3 
times the ocular dose per unit DAP as the next closest 
consultant (Table 6). This may be due to various factors 
influencing operator radiation dose, as discussed above, 
but is most likely due to the high screening time and 
DAP values incurred during certain procedures, possibly 
reflecting the complexity across either the range of 
different procedures or the anatomy and pathologies 
encountered during pain management procedures. 
Regardless, these results highlight the need for further 
monitoring to understand this variation. Observing 
workflow may also provide some insight into this pat-
tern, as no major differences in practice were observed. 
The effective dose values recorded indicate that, in 
general, good clinical practice occurs at our site. Con-
sultants engaged in good practice will have a positive 
influence on trainee pain physicians and allied health 
staff. Good clinical practice will also ensure that staff 
and trainees who may be unfamiliar with radiation risks 
early in their career learn safe techniques when using 
ionizing radiation. 
Interestingly, we did not demonstrate any differ-
ence in IR values for the left and right eye monitors 
worn by consultant 1 in either the pilot or the main 
study. A higher dose to the left eye is a trend that has 
been observed in several other studies in this field 
(29,30). This difference may be explained by the funda-
mental difference between the work practices of pain 
physicians and other interventionalists, such as those in 
cardiology and radiology. Pain physicians are not static 
in one position and very often need to move within the 
exposure field, potentially receiving IR on either side of 
the body/face. We should also consider that this data 
reflects the work practices of an individual practitioner. 
Additional bi-ocular monitoring over a larger cohort 
would be required to make inferences in regard to this 
observation.
Limitations
We recognize that the level of interventional ex-
perience is a fundamental factor influencing operator 
radiation dose, and therefore a small single-centered 
cohort is a limitation. However, we sought to establish 
“best practice” and so we enrolled only the most ex-
perienced individuals (all consultant staff at this site). 
We ensured that we achieved full compliance. For these 
reasons, we believe that this study is a reasonable rep-
resentation of activity in an average pain unit, thereby 
making it clinically relevant to the practice of a typical 
pain physician. Even if the IR and DAP were underes-
timated in our center, the fact that the level of IR was 
significantly less than recommended guidelines allows 
for significant scope in this regard. 
We are conscious that in many centers, including 
our own, fluoroscopy procedures are undertaken by 
pain fellows or resident/registrar with varying levels 
of experience. We would anticipate that individuals 
with less experience in pain interventions would have 
greater screening time and therefore higher DAP and 
IR exposure. Acknowledging the variety of individual 
experiences should be considered in future assessments. 
We had some technical limitations associated with 
our study. Firstly, we did not perform concurrent moni-
toring of Consultant 1 with both ELDs and WBDs. This 
was a missed opportunity for comparison of dose esti-
mation methods, which would have provided an inter-
esting technical aspect to the recorded doses. Secondly, 
it is possible that because the consultants in the study 
were aware that they were being monitored, they may 
have paid greater attention to their technique relative 
to their typical practices. Prolonging the duration of the 
study and using double blinding could reduce this po-
tential bias. Thirdly, the ELDs used, while deemed suit-
able in the literature, were not calibrated to Hp(3) using 
a cylindrical phantom representative of a head. Instead, 
the ELDs used in this study were calibrated to Hp(0.07). 
However, there are many dosimeters calibrated to Hp(3) 
available and under the circumstances, it can be argued 
that this study used the 2 most accepted methods of 
dose estimation in the absence of dosimeters calibrated 
to Hp(3). 
It is accepted that the use of WBDs to determine 
level of risk is reasonable, and that other dosimeters 
can then provide more accurate estimations via ELDs 
(18). This would have been incumbent on us if the esti-







Consultant 1 715 3.69 5.16 x 10-3
Consultant 2 2429 3.51 1.44 x 10-3
Consultant 3 541 0.99 1.83 x 10-3
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mations provided by the WLDs had been closer to the 
new dose limit of 20mSv.
conclusion
We report that exposure to IR in the ocular re-
gion associated with pain procedures is well below 
the new recommended level. Therefore, it is most 
likely that, in many centers, no additional equipment 
or room modifications will be required to meet the new 
recommendations.
We do recommend that future research should 
consider the use of multiple sites, a longer study dura-
tion, greater blinding, and expansion of the study to 
include a mixture of personnel with different levels of 
experience to confirm these findings. We also encour-
age departments to discuss the importance of good 
interventional technique to minimize IR exposure to 
healthcare workers and their patients.
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